Sally Hodder, MD, and Paul Sax, MD, provide their expert perspectives on best practices in managing women with HIV. They consider current antiretroviral therapy (ART) recommendations for women with HIV; review emerging clinical data for novel combinations; and discuss benefits and risks associated with ART in pregnancy.

Content Areas

  • Recent approvals
  • Emerging clinical data
  • Opportunities for HIV testing
  • Initial ART for treatment-naïve women
  • Benefits and risks of ART in pregnancy
  • Best practices in initiating ART
  • Considerations in therapy selection
  • Postpartum management

Target Audience

This activity was developed for HIV specialists, infectious disease specialists, obstetricians/gynecologists, primary care clinicians, and other health care providers who care for women with HIV or at risk of HIV.

Faculty

Sally L. Hodder, MD
Sally L. Hodder, MD
Associate Vice President
Clinical & Translational Science
Director, Clinical & Translational Science Institute
Professor of Medicine
West Virginia University
Morgantown, West Virginia
Paul Edward Sax, MD
Paul Edward Sax, MD
Clinical Director
Professor of Medicine
Harvard Medical School
Brigham and Women's Hospital, Division of Infectious Diseases
Boston, Massachusetts
Enter your information to begin.
CME Credit
Available Credit: 1.00 AMA PRA Category 1 Credit™.
Opens: February 28, 2019
Expires: February 27, 2020
Target Audience: HIV Specialists
Infectious Disease Specialists
Obstetricians
Gynecologists
Primary Care Physicians
Other Health Care Providers
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.